Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

Gastric cancer and gastrin: on the interaction of Helicobacter pylori gastritis and acid inhibitory induced hypergastrinemia

Research output: Contribution to journalJournal articleResearchpeer-review

  1. Plasma calprotectin is superior to serum calprotectin as a biomarker of intestinal inflammation in ulcerative Colitis

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. The clinical course of common bile duct stone clearance with endoscopic retrograde cholangio-pancreaticography

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. The microbiome reflects diagnosis and predicts disease severity in paediatric onset inflammatory bowel disease

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. Dairy products influence gut hormone secretion and appetite differently: A randomized controlled crossover trial

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Intestinal sensing and handling of dietary lipids in gastric bypass-operated patients and matched controls

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Gastric peptides - gastrin and somatostatin

    Research output: Contribution to journalJournal articleResearchpeer-review

View graph of relations

Gastric cancer, a disease with a reduced frequency for decades, now appears to be on the rise again in young Americans. The epidemiology of gastric cancer differs between tumors in the cardia and those of the more distal parts of the stomach. The tumors are divided into the intestinal type showing glandular growth pattern and the diffuse type with a different pattern. The latter often expresses neuroendocrine and more specifically ECL-cell markers suggesting that they originate from the ECL cell, the target cell for the antral hormone, gastrin. Helicobacter pylori gastritis is accepted as the major cause of gastric cancer, but only after having induced oxyntic atrophy which reduces gastric acid secretion and thus induces hypoacidity leading to hypergastrinemia. Long-term hypergastrinemia is known to induce malignant neoplasia in the stomach of animals as well as man. Recently treatment with proton pump inhibitor after Helicobacter pylori eradication in patients with gastroesophageal reflux disease, has been reported to predispose to gastric cancer. Since profound acid inhibition is a well-known cause of gastric neoplasia, it is to be expected that Helicobacter pylori infection and profound acid inhibition has an additive or possibly potentiating effect on the development of gastric cancer.

Original languageEnglish
JournalScandinavian Journal of Gastroenterology
Volume54
Issue number9
Pages (from-to)1118-1123
Number of pages6
ISSN0036-5521
DOIs
Publication statusPublished - Sep 2019

ID: 58076743